# APOE — Apolipoprotein E
URL: https://genohealth.app/genes/apoe
Category: Cardiovascular & lipids
Chromosome: 19q13.32
Key variants: rs429358, rs7412 (define ε2/ε3/ε4)
Last reviewed: 2026-04-25

## Summary
APOE produces a protein that transports cholesterol in blood and brain. Its three alleles (ε2, ε3, ε4) defined by rs429358 + rs7412 shape your lipid profile and your risk for late-onset Alzheimer's disease and cardiovascular disease.

## What it does
APOE carries cholesterol and other lipids between cells and tissues, including across the blood-brain barrier. Different versions of the gene (ε2, ε3, ε4) clear cholesterol with different efficiency, bind LDL receptors with different affinity, and interact differently with neurons in the brain — particularly in clearing beta-amyloid, the protein that accumulates in Alzheimer's disease.

## Why it matters
ε4 carriers tend to have higher LDL cholesterol and a substantially elevated risk of late-onset Alzheimer's disease (one ε4 ≈ 2-3x; two ε4 ≈ 8-12x lifetime risk vs. ε3/ε3). ε2 carriers are generally protected against Alzheimer's but may have higher triglycerides and rare type-III hyperlipidemia. Knowing your genotype changes how you should interpret blood lipids, design diet, and prioritize aerobic exercise — which has outsized cognitive benefit in ε4 carriers.

## Variants
- rs429358 — risk allele n/a; Defines ε4 vs ε3/ε2 (C = ε4 allele) (frequency: C allele ≈14% globally)
- rs7412 — risk allele n/a; Defines ε2 vs ε3/ε4 (T = ε2 allele) (frequency: T allele ≈8% globally)

## Genotypes
- **ε3/ε3** (~60% of Europeans): Average cholesterol handling and Alzheimer risk. → Standard heart-healthy lifestyle; no genotype-specific intervention.
- **ε3/ε4** (~20-25%): Elevated LDL; ~2-3x lifetime Alzheimer risk vs ε3/ε3. → Mediterranean / MIND diet, 150+ min/wk aerobic exercise, monitor ApoB and Lp(a).
- **ε4/ε4** (~2-3%): Highest LDL; ~8-12x lifetime Alzheimer risk. → Aggressive lifestyle — Mediterranean diet, daily aerobic exercise, sleep optimization, alcohol minimization, hearing protection. Discuss statin/PCSK9 with cardiologist.
- **ε2/ε3 or ε2/ε2** (~13%): Lower Alzheimer risk; potentially elevated triglycerides; rare type-III hyperlipidemia in ε2/ε2. → Watch triglycerides; limit refined carbs and alcohol; standard lipid screening.

## Conditions
- **Late-onset Alzheimer's disease** — Increased risk (ε4) / Protective (ε2): ε4 is the strongest known common genetic risk factor; ε2 is the strongest protective allele. Risk is modified by lifestyle, sleep, and cardiovascular health.
- **Coronary artery disease** — Modestly increased risk (ε4): Mediated by elevated LDL and plaque accumulation; benefits from standard cardiovascular prevention.
- **Type-III hyperlipoproteinemia** — Strongly increased risk (ε2/ε2 only): Rare; characterized by elevated chylomicron remnants and triglycerides; specialist management.
- **Traumatic brain injury recovery** — Worse outcomes (ε4): ε4 carriers recover more slowly from TBI; relevant for athletes and veterans.

## Diet
Rationale: ε4 carriers absorb saturated fat more efficiently and are more sensitive to its LDL-raising effect. The Mediterranean and MIND diets are the only patterns with RCT evidence for cognitive benefit, with the strongest signal in ε4 carriers.
Prioritize: Extra-virgin olive oil (1-2 tbsp/day); Fatty fish 2-3x/week (salmon, sardines); Leafy greens daily; Berries 3+ servings/week; Nuts (walnuts, almonds) 30g/day; Beans and lentils
Limit: Saturated fat (red meat, butter, coconut oil) — ε4 carriers absorb more; Refined carbs and added sugar; Ultra-processed foods; Alcohol (>5 drinks/week)

## Lifestyle
- 150-300 minutes/week of moderate aerobic exercise — strongest single intervention for ε4 cognition.
- Sleep 7-9 hours; treat sleep apnea aggressively (it accelerates amyloid accumulation).
- Protect hearing — untreated hearing loss is a major modifiable Alzheimer risk factor.
- Stay socially and cognitively engaged; learn new skills throughout life.
- Manage blood pressure to <130/80 from midlife onward.

## Supplements
- **Omega-3 (DHA-dominant)** — 1-2 g DHA/day, form: Triglyceride-form fish oil or algae oil. Strongest evidence in ε4 carriers BEFORE cognitive symptoms appear; less benefit after onset.
- **Vitamin D3** — 2000-4000 IU/day to reach 25(OH)D 40-60 ng/mL, form: D3 with K2 (MK-7). Low D linked to faster cognitive decline.
- **Curcumin (with piperine or phytosomal)** — 500-1000 mg/day, form: Meriva or BCM-95. Crosses blood-brain barrier; modest evidence for cognition.
- **Citicoline (CDP-choline)** — 250-500 mg/day, form: Standard. Supports membrane phospholipids; some evidence in mild cognitive impairment.

## Contraindications
- ε4/ε4 carriers should not start hormone replacement therapy without specialist input — some studies suggest worse cognitive outcomes.
- High-dose vitamin E (>400 IU/day) may increase mortality and is no longer recommended for Alzheimer prevention.
- Coconut oil and MCT oil for cognition lack RCT support and raise LDL in ε4 carriers — not recommended.

## FAQ
**Q: Does APOE ε4 mean I will get Alzheimer's?**
A: No. ε4 raises lifetime risk but is neither necessary nor sufficient. About 40-65% of people with Alzheimer's carry at least one ε4, but many ε4 carriers — even ε4/ε4 — never develop the disease, and many non-carriers do.

**Q: What is the best diet for APOE4?**
A: Mediterranean and MIND diets have the strongest evidence: olive oil, fatty fish, leafy greens, berries, nuts, beans, with low saturated fat and refined carbs. Avoid coconut oil and MCT oil — they raise LDL in ε4 carriers without proven cognitive benefit.

**Q: Should APOE4 carriers take fish oil?**
A: Likely yes, if started in midlife before symptoms — 1-2 g/day of DHA-dominant omega-3. The evidence weakens once cognitive impairment is established.

**Q: Do APOE4 carriers need statins?**
A: Decision should be individualized with a cardiologist based on ApoB, Lp(a), 10-year risk, and family history — not on APOE genotype alone. ε4 itself does not change statin response meaningfully.

**Q: Is APOE2 always good?**
A: ε2 lowers Alzheimer risk but ε2/ε2 carriers can develop type-III hyperlipoproteinemia (high triglycerides + cholesterol). One ε2 (ε2/ε3) is generally favorable.

**Q: Should I get tested if I'm worried about Alzheimer's?**
A: Knowing your APOE genotype is informative but emotionally significant and not always clinically actionable. Consider genetic counseling first. The lifestyle interventions that benefit ε4 carriers benefit everyone.

## Citations
- Corder et al., Science 1993 (PMID 8346443): Original report linking APOE ε4 dose to Alzheimer risk.
- Yassine et al., JAMA Neurol 2017 (PMID 28628716): DHA supplementation increases brain DHA more in ε4 non-carriers; intervention timing matters.
- Livingston et al., Lancet Commission 2020 (PMID 32738937): 12 modifiable risk factors account for ~40% of dementia risk; relevant for ε4 carriers.

Disclaimer: Informational only — not medical advice.